Cargando…
Re-thinking Alzheimer's disease therapeutic targets using gene-based tests
BACKGROUND: Alzheimer's disease (AD) is a devastating condition with no known effective drug treatments. Existing drugs only alleviate symptoms. Given repeated expensive drug failures, we assessed systematically whether approved and investigational AD drugs are targeting products of genes stron...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6446018/ https://www.ncbi.nlm.nih.gov/pubmed/30314892 http://dx.doi.org/10.1016/j.ebiom.2018.10.001 |